FINAL ALLR DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Allarity Therapeutics, Inc. Investors to Join the Class Action Lawsuit!
Portfolio Pulse from
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Allarity Therapeutics, Inc. (NASDAQ:ALLR) and certain officers for alleged violations of federal securities laws. The lawsuit covers investors who acquired Allarity securities between May 17, 2022, and July 19, 2024.
November 11, 2024 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A class action lawsuit has been filed against Allarity Therapeutics, Inc. for alleged securities law violations, potentially impacting its stock price.
The filing of a class action lawsuit against Allarity Therapeutics for alleged securities violations is likely to negatively impact investor sentiment and the stock price in the short term. Legal issues can lead to uncertainty and potential financial liabilities, which typically result in downward pressure on stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100